Biology and clinical relevance of EpCAM

Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein primarily known to mediate homotypic cell contacts in epithelia tissues. Because EpCAM expression is limited to normal and malignant epithelia, it has been used as diagnostic marker for the detection of carcinoma cells in mese...

Full description

Saved in:
Bibliographic Details
Published inCell Stress Vol. 3; no. 6; pp. 165 - 180
Main Authors Keller, Laura, Werner, Stefan, Pantel, Klaus
Format Journal Article
LanguageEnglish
Published Austria Shared Science Publishers OG 21.05.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein primarily known to mediate homotypic cell contacts in epithelia tissues. Because EpCAM expression is limited to normal and malignant epithelia, it has been used as diagnostic marker for the detection of carcinoma cells in mesenchymal organs such as blood, bone marrow or lymph nodes. In particular, the detection and molecular characterization of EpCAM-positive circulating tumor cells (CTCs) in the blood of carcinoma patients has gained considerable interest over the past ten years. EpCAM is primarily considered as an adhesion molecule, but recent studies have shown diverse biological functions including regulation of cell proliferation and cancer stemness. In this review, we summarize the current knowledge on the biological properties of EpCAM with emphasis on mechanisms involved in cancer progression and discuss the clinical implications of these findings for the clinical use of EpCAM as a diagnostic marker.
AbstractList Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein primarily known to mediate homotypic cell contacts in epithelia tissues. Because EpCAM expression is limited to normal and malignant epithelia, it has been used as diagnostic marker for the detection of carcinoma cells in mesenchymal organs such as blood, bone marrow or lymph nodes. In particular, the detection and molecular characterization of EpCAM-positive circulating tumor cells (CTCs) in the blood of carcinoma patients has gained considerable interest over the past ten years. EpCAM is primarily considered as an adhesion molecule, but recent studies have shown diverse biological functions including regulation of cell proliferation and cancer stemness. In this review, we summarize the current knowledge on the biological properties of EpCAM with emphasis on mechanisms involved in cancer progression and discuss the clinical implications of these findings for the clinical use of EpCAM as a diagnostic marker.
Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein primarily known to mediate homotypic cell contacts in epithelia tissues. Because EpCAM expression is limited to normal and malignant epithelia, it has been used as diagnostic marker for the detection of carcinoma cells in mesenchymal organs such as blood, bone marrow or lymph nodes. In particular, the detection and molecular characterization of EpCAM-positive circulating tumor cells (CTCs) in the blood of carcinoma patients has gained considerable interest over the past ten years. EpCAM is primarily considered as an adhesion molecule, but recent studies have shown diverse biological functions including regulation of cell proliferation and cancer stemness. In this review, we summarize the current knowledge on the biological properties of EpCAM with emphasis on mechanisms involved in cancer progression and discuss the clinical implications of these findings for the clinical use of EpCAM as a diagnostic marker.Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein primarily known to mediate homotypic cell contacts in epithelia tissues. Because EpCAM expression is limited to normal and malignant epithelia, it has been used as diagnostic marker for the detection of carcinoma cells in mesenchymal organs such as blood, bone marrow or lymph nodes. In particular, the detection and molecular characterization of EpCAM-positive circulating tumor cells (CTCs) in the blood of carcinoma patients has gained considerable interest over the past ten years. EpCAM is primarily considered as an adhesion molecule, but recent studies have shown diverse biological functions including regulation of cell proliferation and cancer stemness. In this review, we summarize the current knowledge on the biological properties of EpCAM with emphasis on mechanisms involved in cancer progression and discuss the clinical implications of these findings for the clinical use of EpCAM as a diagnostic marker.
Author Keller, Laura
Pantel, Klaus
Werner, Stefan
Author_xml – sequence: 1
  givenname: Laura
  surname: Keller
  fullname: Keller, Laura
– sequence: 2
  givenname: Stefan
  surname: Werner
  fullname: Werner, Stefan
– sequence: 3
  givenname: Klaus
  surname: Pantel
  fullname: Pantel, Klaus
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31225512$$D View this record in MEDLINE/PubMed
https://hal.science/hal-04954701$$DView record in HAL
BookMark eNp1ks1PGzEQxS1EBZRy5lbtre0hwd9rXyqlES1IqXopZ8se28HIWafeTST--25IqACpJ1vj936e0bz36LgrXUDokuApEVKrK-gHiomeYjklSh2hMyoom2CK-fGL-ym66PsHjDElUrVCnqBTRigVgtAz9OlbKrksHxvb-QZy6hLY3NSQw9Z2EJoSm-v1fPbzA3oXbe7DxeE8R3ffr3_PbyaLXz9u57PFBLhmwyS6CEC9Y95qSp1SRNEQMbSti1hzHWiUQtPWtcQHDo7iCC3BWsYAXirLztHtnuuLfTDrmla2Pppik3kqlLo0tg4JcjDMw-hijjjhePTBKYGBSM2U2M0OI-vrnrXeuFXwELqh2vwK-vqlS_dmWbZGCqE04yPgyx5w_8Z2M1uYXQ1zLXiLyZaM2s-Hz2r5swn9YFaph5Cz7ULZ9IZSLiQnrcCj9OPLvv6Rn7cyCsReALX0fQ3RQBrskMquzZQNweYpAOYQAIOlGQMw-q7e-J7R_3P8BaGIsPw
CitedBy_id crossref_primary_10_1038_s41598_024_83061_8
crossref_primary_10_1016_j_humpath_2020_04_005
crossref_primary_10_1021_jacs_3c02625
crossref_primary_10_1038_s41557_022_01057_1
crossref_primary_10_1002_1878_0261_13092
crossref_primary_10_1186_s13045_022_01347_8
crossref_primary_10_1089_cmb_2020_0364
crossref_primary_10_1515_biol_2022_0780
crossref_primary_10_1038_s41416_023_02179_0
crossref_primary_10_1016_j_snb_2023_133784
crossref_primary_10_1134_S1990750820030099
crossref_primary_10_3390_ijms232314687
crossref_primary_10_1002_cam4_5429
crossref_primary_10_1186_s12935_022_02658_z
crossref_primary_10_1016_j_bbrep_2021_101074
crossref_primary_10_1155_ijso_2621591
crossref_primary_10_3390_ijms21249457
crossref_primary_10_18097_pbmc20206601095
crossref_primary_10_2217_pgs_2021_0099
crossref_primary_10_2147_OTT_S386562
crossref_primary_10_3390_pharmaceutics14122561
crossref_primary_10_1007_s12672_025_02095_0
crossref_primary_10_1007_s40291_024_00734_w
crossref_primary_10_3390_microorganisms8111753
crossref_primary_10_1016_j_bios_2021_113594
crossref_primary_10_3390_cells9081836
crossref_primary_10_1002_pros_23896
crossref_primary_10_1039_D3AN01011B
crossref_primary_10_1016_j_heliyon_2023_e13044
crossref_primary_10_3389_fnmol_2021_809878
crossref_primary_10_3389_fncel_2023_1170309
crossref_primary_10_1016_j_gene_2023_147905
crossref_primary_10_1038_s41392_024_01938_6
crossref_primary_10_3390_cancers12061632
crossref_primary_10_1038_s41598_023_30733_6
crossref_primary_10_1016_j_cpt_2024_01_001
crossref_primary_10_1373_clinchem_2019_303339
crossref_primary_10_1080_17476348_2024_2388288
crossref_primary_10_3390_app10144854
crossref_primary_10_1007_s00281_025_01042_z
crossref_primary_10_1007_s40336_021_00444_x
crossref_primary_10_3390_photonics9120955
crossref_primary_10_1007_s13258_021_01211_y
crossref_primary_10_1016_j_oraloncology_2023_106433
crossref_primary_10_3389_fonc_2022_843879
crossref_primary_10_1021_acs_langmuir_1c01998
crossref_primary_10_1016_j_jncc_2024_07_003
crossref_primary_10_1177_17588359241284935
crossref_primary_10_1016_j_sna_2024_115229
crossref_primary_10_3390_cancers13071719
crossref_primary_10_1038_s41467_021_22482_9
crossref_primary_10_1186_s12935_021_01858_3
crossref_primary_10_1016_j_aca_2025_343623
crossref_primary_10_3390_diagnostics12020497
crossref_primary_10_1021_acsmaterialslett_3c00616
crossref_primary_10_1016_j_talanta_2024_127127
crossref_primary_10_3390_app112210787
crossref_primary_10_3390_cells11162570
crossref_primary_10_1002_smtd_202200717
crossref_primary_10_1016_j_bioadv_2022_213077
crossref_primary_10_1371_journal_pbio_3001394
crossref_primary_10_1016_j_ijom_2021_05_020
crossref_primary_10_1016_j_inoche_2024_112409
crossref_primary_10_1021_jacs_3c09545
crossref_primary_10_12688_f1000research_27393_2
crossref_primary_10_12688_f1000research_27393_1
crossref_primary_10_1080_14712598_2021_1922665
crossref_primary_10_12688_f1000research_27393_3
crossref_primary_10_1007_s10585_021_10120_z
crossref_primary_10_3389_fbioe_2020_00897
crossref_primary_10_3390_cells9061361
crossref_primary_10_3389_fendo_2022_941166
crossref_primary_10_1136_jitc_2022_005615
crossref_primary_10_1038_s41467_022_28788_6
crossref_primary_10_1186_s12871_021_01479_3
crossref_primary_10_3389_fbioe_2023_1144209
crossref_primary_10_1093_biomethods_bpaf009
crossref_primary_10_1007_s12672_025_01846_3
crossref_primary_10_3389_fonc_2022_1090503
crossref_primary_10_1038_s41416_024_02576_z
crossref_primary_10_1021_acsanm_2c02078
crossref_primary_10_1002_1878_0261_12997
crossref_primary_10_1016_j_bios_2024_116050
crossref_primary_10_1016_j_apmt_2020_100701
crossref_primary_10_3390_chemosensors11060335
crossref_primary_10_3390_cells9071691
crossref_primary_10_1371_journal_pone_0241123
crossref_primary_10_3390_bioengineering9080380
crossref_primary_10_1016_j_semcancer_2020_12_002
crossref_primary_10_1155_2020_4821056
crossref_primary_10_3390_ijms231911983
crossref_primary_10_2174_1381612829666230420083431
crossref_primary_10_4252_wjsc_v12_i11_1295
crossref_primary_10_1080_14728222_2022_2077188
crossref_primary_10_17650_1994_4098_2021_17_4_90_95
crossref_primary_10_3390_cancers14174121
crossref_primary_10_3390_cancers14112810
crossref_primary_10_3389_fcell_2024_1441081
crossref_primary_10_3390_cells9092128
crossref_primary_10_3390_cancers12113328
crossref_primary_10_3390_cancers14194596
crossref_primary_10_1007_s40291_023_00680_z
crossref_primary_10_1016_j_bbcan_2024_189236
crossref_primary_10_1186_s12885_020_07580_z
crossref_primary_10_1007_s00432_023_04809_9
crossref_primary_10_1016_j_talanta_2023_124548
crossref_primary_10_1016_j_prp_2024_155378
crossref_primary_10_1002_jev2_12039
crossref_primary_10_1021_acsami_0c20916
crossref_primary_10_3390_ijms221910640
crossref_primary_10_1002_smll_202106097
crossref_primary_10_3390_biomedicines10112985
crossref_primary_10_3389_fimmu_2024_1402951
crossref_primary_10_1016_j_colsurfa_2024_135176
crossref_primary_10_15252_emmm_201911908
crossref_primary_10_1016_j_bbrc_2022_01_120
crossref_primary_10_1186_s12951_022_01256_5
crossref_primary_10_1016_j_isci_2021_103179
crossref_primary_10_3389_fonc_2021_672262
crossref_primary_10_3390_diagnostics13162652
crossref_primary_10_1016_j_yexcr_2021_112685
crossref_primary_10_3390_cancers14153595
crossref_primary_10_1007_s10555_020_09898_3
crossref_primary_10_1093_clinchem_hvaa322
crossref_primary_10_1007_s12015_020_10045_2
crossref_primary_10_3390_ijms25137109
crossref_primary_10_1002_admt_202001138
crossref_primary_10_15252_embj_2021109221
crossref_primary_10_3390_diagnostics11030544
crossref_primary_10_3389_fgene_2020_00312
crossref_primary_10_1186_s13072_022_00449_4
crossref_primary_10_7554_eLife_90298
crossref_primary_10_3390_ijms24054554
crossref_primary_10_3390_life11090915
crossref_primary_10_18632_aging_206024
crossref_primary_10_1021_acssensors_2c01750
crossref_primary_10_1007_s00432_023_04767_2
ContentType Journal Article
Copyright Distributed under a Creative Commons Attribution 4.0 International License
Copyright: © 2019 Keller et al. 2019
Copyright_xml – notice: Distributed under a Creative Commons Attribution 4.0 International License
– notice: Copyright: © 2019 Keller et al. 2019
DBID AAYXX
CITATION
NPM
7X8
1XC
5PM
DOA
DOI 10.15698/cst2019.06.188
DatabaseName CrossRef
PubMed
MEDLINE - Academic
Hyper Article en Ligne (HAL)
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate EpCAM biology and functions
EISSN 2523-0204
EndPage 180
ExternalDocumentID oai_doaj_org_article_3dcfec3b1b5b4fdeb850c1693852523c
PMC6558934
oai_HAL_hal_04954701v1
31225512
10_15698_cst2019_06_188
Genre Journal Article
Review
GroupedDBID AAFWJ
AAYXX
ADBBV
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
CITATION
GROUPED_DOAJ
HYE
M~E
OK1
RPM
NPM
7X8
1XC
5PM
ID FETCH-LOGICAL-c493t-fbfcc2db3da922b88182ef0c77bf0949e2f65927b71de4cb20fc71096fecd68a3
IEDL.DBID DOA
ISSN 2523-0204
IngestDate Wed Aug 27 01:21:18 EDT 2025
Thu Aug 21 18:03:07 EDT 2025
Fri May 09 12:17:26 EDT 2025
Fri Jul 11 00:03:19 EDT 2025
Thu Jan 02 23:01:38 EST 2025
Tue Jul 01 00:55:01 EDT 2025
Thu Apr 24 23:02:34 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Tumor biomarker
EpCAM
circulating tumor cells
EMT
liquid biopsy
tumor cell dissemination
Language English
License Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
This is an open-access article released under the terms of the Creative Commons Attribution (CC BY) license, which allows the unrestricted use, distribution, and reproduction in any medium, provided the original author and source are acknowledged.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c493t-fbfcc2db3da922b88182ef0c77bf0949e2f65927b71de4cb20fc71096fecd68a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Please cite this article as: Laura Keller, Stefan Werner and Klaus Pantel (2019). Biology and clinical relevance of EpCAM. Cell Stress 3(6): 165-180. doi: 10.15698/cst2019.06.188
Conflict of interest: K.P. has ongoing patent applications related to circulating tumor cells. K.P. has received honoraria from Agena, Novartis, Roche and Sanofi and research funding from European Federation of Pharmaceutical Industries and Associations (EFPIA) partners (Angle, Menarini and Servier) of the CANCER-ID programme of the European Union–EFPIA Innovative Medicines Initiative. L.K and S.W. declare no conflict of interest.
OpenAccessLink https://doaj.org/article/3dcfec3b1b5b4fdeb850c1693852523c
PMID 31225512
PQID 2245641750
PQPubID 23479
PageCount 16
ParticipantIDs doaj_primary_oai_doaj_org_article_3dcfec3b1b5b4fdeb850c1693852523c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6558934
hal_primary_oai_HAL_hal_04954701v1
proquest_miscellaneous_2245641750
pubmed_primary_31225512
crossref_citationtrail_10_15698_cst2019_06_188
crossref_primary_10_15698_cst2019_06_188
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20190521
PublicationDateYYYYMMDD 2019-05-21
PublicationDate_xml – month: 5
  year: 2019
  text: 20190521
  day: 21
PublicationDecade 2010
PublicationPlace Austria
PublicationPlace_xml – name: Austria
PublicationTitle Cell Stress
PublicationTitleAlternate Cell Stress
PublicationYear 2019
Publisher Shared Science Publishers OG
Publisher_xml – name: Shared Science Publishers OG
SSID ssj0002168756
Score 2.468528
SecondaryResourceType review_article
Snippet Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein primarily known to mediate homotypic cell contacts in epithelia tissues. Because...
SourceID doaj
pubmedcentral
hal
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 165
SubjectTerms circulating tumor cells
EMT
EpCAM
Life Sciences
liquid biopsy
Review
Tumor biomarker
tumor cell dissemination
Title Biology and clinical relevance of EpCAM
URI https://www.ncbi.nlm.nih.gov/pubmed/31225512
https://www.proquest.com/docview/2245641750
https://hal.science/hal-04954701
https://pubmed.ncbi.nlm.nih.gov/PMC6558934
https://doaj.org/article/3dcfec3b1b5b4fdeb850c1693852523c
Volume 3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYqTr1UlL7SQuVWFeVAwHHs2DluEWhVlYoDSNysjB-iUpVF7IK0_56ZJPuiqnrp1bGd5JuxZ0Yef8PYlwC68Y0SuQw25CqCzcHUPkflsQFiLb2n-87nP6vxlfp-ra_XSn1RTlhPD9wDd1wGn6IvoQANKgWcTAtPDCJWSwyiPO2-aPPWginag2VRoSNeDVw-uqrtsZ_O0NjVxNZZdHVWVmaoY-tH43JDuZB_OppP8yXXDNDZNnsxeI581H_xS_Ystjts_6Knnp4f8svVTarpId_nFytS6vkr9rUvOjnnTRv44jokp4opXQ4AnyR-ensyOn_Nrs5OL0_G-VAkIfeqLmd5guS9DFCGppYSLBpgGZPwxkDC0K2OMtHJqQFThKg8SJE85V9WiGqobFO-YVvtpI3vGDcheNFoENFGJQBR0gABpIzGQmNSxo4WmDk_MIhTIYvfjiIJAtkNIDtRORyesYPlgNuePOPvXb-REJbdiPW6a0BdcIMuuH_pQsY-owg35hiPfjhqw0BIKyOKhyJjnxYSdriU6HykaePkfuokHQIr9KdExt72El_OVRa48aFzlDGzoQsbL9t80v666ei6K63RKVTv_8cffmDPCTRKX5DFLtua3d3HPfSKZvCxWwCPTQ4MGA
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Biology+and+clinical+relevance+of+EpCAM&rft.jtitle=Cell+Stress&rft.au=Keller%2C+Laura&rft.au=Werner%2C+Stefan&rft.au=Pantel%2C+Klaus&rft.date=2019-05-21&rft.pub=Shared+Science+Publishers+OG&rft.eissn=2523-0204&rft.volume=3&rft.issue=6&rft.spage=165&rft.epage=180&rft_id=info:doi/10.15698%2Fcst2019.06.188&rft_id=info%3Apmid%2F31225512&rft.externalDocID=PMC6558934
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2523-0204&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2523-0204&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2523-0204&client=summon